Review

Get Permission
Rev Diabet Stud, 2010, 7(2):112-123 DOI 10.1900/RDS.2010.7.112

The Quest for Tissue Stem Cells in the Pancreas and Other Organs, and their Application in Beta-Cell Replacement

Isabelle Houbracken, Luc Bouwens

Cell Differentiation Lab, Diabetes Research Center, Vrije Universiteit Brussel (Free University of Brussels), Laarbeeklaan 103, 1090 - Brussels, Belgium
Address correspondence to: Luc Bouwens, e-mail: lucbo@vub.ac.be

Manuscript submitted July 4, 2010; resubmitted July 7, 2010; accepted July 10, 2010.

Keywords: stem cell, duct, progenitor, beta-cell, acinar, transdifferentiation, lineage tracing, reprogramming

Abstract

Adult stem cell research has drawn a lot of attention by many researchers, due to its medical hope of cell replacement or regenerative therapy for diabetes patients. Despite the many research efforts to date, there is no consensus on the existence of stem cells in adult pancreas. Genetic lineage tracing experiments have put into serious doubt whether β-cell neogenesis from stem/progenitor cells takes place postnatally. Different in vitro experiments have suggested centroacinar, ductal, acinar, stellate, or yet unidentified clonigenic cells as candidate β-cell progenitors. As in the rest of the adult stem cell field, sound and promising observations have been made. However, these observations still need to be replicated. As an alternative to committed stem/progenitor cells in the pancreas, transdifferentiation or lineage reprogramming of exocrine acinar and endocrine α-cells may be used to generate new β-cells. At present, it is unclear which approach is most medically promising. This article highlights the progress being made in knowledge about tissue stem cells, their existence and availability for therapy in diabetes. Particular attention is given to the assessment of methods to verify the existence of tissue stem cells.

Fulltext: HTML , PDF (576KB)


This article has been cited by other articles:

Concise review: clinical programs of stem cell therapies for liver and pancreas

Lanzoni G, Oikawa T, Wang Y, Cui CB, Carpino G, Cardinale V, Gerber D, Gabriel M, Dominguez-Bendala J, Furth ME, Gaudio E, Alvaro D, Inverardi L, Reid LM

Stem Cells 2013. 31(10):2047-2060

The use of stem cells for pancreatic regeneration in diabetes mellitus

Bouwens L, Houbracken I, Mfopou JK

Nat Rev Endocrinol 2013. 9(10):598-606

Research progress of stem cell therapy for type 1 diabetes mellitus

Hu MJ, Pan XH, Pang RQ, Cai XM

Chin J Tissue Engin Res 2012. 16(23):4349-4353

Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors

Hindriksen S, Bijlsma MF

Cancers (Basel) 2012. 4(4):989-1035

Identifying thyroid stem/progenitor cells: advances and limitations

Fierabracci A

J Endocrinol 2011. In press

Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration

Chung CH, Levine F

Rev Diabet Stud 2010. 7(2):124-131